InvestorsHub Logo
Followers 94
Posts 2355
Boards Moderated 0
Alias Born 11/07/2017

Re: SAMNOTSAMUEL post# 37104

Sunday, 03/25/2018 6:12:15 PM

Sunday, March 25, 2018 6:12:15 PM

Post# of 50157
DELCATH SYSTEMS, INC.
Notes to Consolidated Financial Statements
for the Years Ended December 31, 2017, 2016 and 2015

(7) Current Accrued Expenses

Current accrued expenses include the following:
(in thousands)
2017 2016
Clinical trial expenses $869 $1,365
Compensation, excluding taxes $1,124 $933

Tried copy and paste but doesn't work with tables.

So, I am not a financial guy as stated on more than one occasion but, seems to me trial expenses went down and compensation went up while investors lost their behinds (unless I am reading it wrong).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News